Bioptik Technology, Inc.(TW:4161)
NT$21.10+0.25 (+1.20%)
TW:4161
Bioptik Technology, Inc. financials statements
NT$21.10
At close:+0.25 (+1.20%)
Bioptik Technology, Inc. (4161) Ratios
Bioptik Technology, Inc. Ratios
TW:4161's free cash flow for Q2 2026 was NT$33.11M. For the 2026 fiscal year, TW:4161's free cash flow was decreased by NT$-3.75M and operating cash flow was NT$36.87M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.93 | 1.93 | 1.69 | 1.41 | 1.41 |
| Quick Ratio | 1.51 | 1.47 | 1.23 | 0.91 | 1.06 |
| Cash Ratio | 0.82 | 0.85 | 0.71 | 0.50 | 0.17 |
| Solvency Ratio | 0.17 | 0.22 | 0.18 | 0.10 | 0.07 |
| Operating Cash Flow Ratio | 0.09 | 0.35 | 0.40 | 0.09 | -0.07 |
| Short-Term Operating Cash Flow Coverage | 0.12 | 0.50 | 0.56 | 0.11 | -0.09 |
| Net Current Asset Value | NT$ 338.41M | NT$ 282.46M | NT$ 198.69M | NT$ 73.38M | NT$ 31.56M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.30 | 0.35 | 0.44 | 0.45 |
| Debt-to-Equity Ratio | 0.49 | 0.50 | 0.64 | 0.93 | 0.99 |
| Debt-to-Capital Ratio | 0.33 | 0.33 | 0.39 | 0.48 | 0.50 |
| Long-Term Debt-to-Capital Ratio | 0.10 | 0.13 | 0.16 | 0.20 | 0.24 |
| Financial Leverage Ratio | 1.62 | 1.65 | 1.83 | 2.12 | 2.21 |
| Debt Service Coverage Ratio | 0.23 | 0.42 | 0.35 | 0.18 | 0.14 |
| Interest Coverage Ratio | 8.77 | 9.86 | 8.21 | 7.81 | 3.47 |
| Debt to Market Cap | 0.33 | 0.32 | 0.36 | 0.55 | 0.57 |
| Interest Debt Per Share | 8.42 | 9.03 | 10.47 | 13.26 | 13.69 |
| Net Debt to EBITDA | 0.72 | 0.45 | 1.02 | 3.34 | 9.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.09% | 30.96% | 28.91% | 23.11% | 22.16% |
| EBIT Margin | 7.97% | 13.80% | 14.18% | 9.38% | 3.72% |
| EBITDA Margin | 11.88% | 17.92% | 18.37% | 13.74% | 8.73% |
| Operating Profit Margin | 7.97% | 10.40% | 10.89% | 9.35% | 3.68% |
| Pretax Profit Margin | 10.19% | 12.75% | 12.85% | 8.18% | 2.66% |
| Net Profit Margin | 8.50% | 10.81% | 10.35% | 6.32% | 3.06% |
| Continuous Operations Profit Margin | 8.34% | 10.67% | 10.21% | 6.13% | 2.79% |
| Net Income Per EBT | 83.44% | 84.82% | 80.50% | 77.22% | 115.17% |
| EBT Per EBIT | 127.85% | 122.59% | 117.98% | 87.50% | 72.27% |
| Return on Assets (ROA) | 4.53% | 6.29% | 5.72% | 3.20% | 1.48% |
| Return on Equity (ROE) | 7.34% | 10.38% | 10.46% | 6.78% | 3.27% |
| Return on Capital Employed (ROCE) | 6.14% | 8.66% | 9.20% | 8.00% | 2.97% |
| Return on Invested Capital (ROIC) | 3.78% | 5.55% | 5.31% | 3.89% | 1.97% |
| Return on Tangible Assets | 4.54% | 6.29% | 5.72% | 3.20% | 1.48% |
| Earnings Yield | 5.03% | 6.75% | 5.91% | 4.03% | 1.90% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.01 | 3.75 | 3.47 | 3.38 | 2.48 |
| Payables Turnover | 9.27 | 10.95 | 7.07 | 8.38 | 5.61 |
| Inventory Turnover | 2.92 | 2.91 | 2.51 | 1.93 | 2.69 |
| Fixed Asset Turnover | 1.69 | 1.71 | 1.58 | 1.46 | 1.36 |
| Asset Turnover | 0.53 | 0.58 | 0.55 | 0.51 | 0.48 |
| Working Capital Turnover Ratio | 1.93 | 2.24 | 2.72 | 3.05 | 2.84 |
| Cash Conversion Cycle | 206.87 | 189.49 | 199.24 | 253.64 | 217.65 |
| Days of Sales Outstanding | 121.33 | 97.34 | 105.21 | 107.93 | 147.16 |
| Days of Inventory Outstanding | 124.92 | 125.49 | 145.65 | 189.28 | 135.59 |
| Days of Payables Outstanding | 39.38 | 33.35 | 51.62 | 43.58 | 65.10 |
| Operating Cycle | 246.25 | 222.83 | 250.86 | 297.21 | 282.75 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.77 | 3.12 | 4.04 | 1.09 | -0.81 |
| Free Cash Flow Per Share | 0.43 | 2.81 | 3.43 | 0.75 | -1.20 |
| Dividend Paid and CapEx Coverage Ratio | 1.25 | 3.02 | 6.63 | 1.74 | -1.20 |
| Capital Expenditure Coverage Ratio | 2.29 | 10.24 | 6.63 | 3.22 | -2.08 |
| Operating Cash Flow Coverage Ratio | 0.09 | 0.35 | 0.39 | 0.08 | -0.06 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.18 | 0.25 | 0.07 | -0.06 |
| Free Cash Flow Yield | 1.74% | 10.33% | 12.05% | 3.15% | -5.12% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 20.28 | 14.79 | 16.93 | 23.77 | 52.24 |
| Price-to-Sales (P/S) Ratio | 1.69 | 1.60 | 1.75 | 1.57 | 1.61 |
| Price-to-Book (P/B) Ratio | 1.46 | 1.54 | 1.77 | 1.68 | 1.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 57.45 | 9.68 | 8.30 | 31.72 | -19.54 |
| Price-to-Operating Cash Flow Ratio | 32.32 | 8.73 | 7.05 | 21.88 | -28.96 |
| Price-to-Earnings Growth (PEG) Ratio | -0.61 | 1.55 | 0.25 | 0.19 | -0.38 |
| Enterprise Value Multiple | 14.95 | 9.40 | 10.55 | 14.76 | 27.53 |
| Enterprise Value | 1.49B | 1.46B | 1.61B | 1.56B | 1.77B |
| EV to EBITDA | 14.95 | 9.40 | 10.55 | 14.76 | 27.53 |
| EV to Sales | 1.78 | 1.68 | 1.94 | 2.03 | 2.40 |
| EV to Free Cash Flow | 60.34 | 10.17 | 9.18 | 41.00 | -29.09 |
| EV to Operating Cash Flow | 33.95 | 9.18 | 7.80 | 28.28 | -43.10 |
| Tangible Book Value Per Share | 17.12 | 17.75 | 16.15 | 14.16 | 13.69 |
| Shareholders’ Equity Per Share | 17.07 | 17.68 | 16.06 | 14.11 | 13.62 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.18 | 0.16 | 0.21 | 0.25 | -0.05 |
| Revenue Per Share | 14.74 | 16.97 | 16.24 | 15.15 | 14.56 |
| Net Income Per Share | 1.25 | 1.84 | 1.68 | 0.96 | 0.45 |
| Tax Burden | 0.83 | 0.85 | 0.81 | 0.77 | 1.15 |
| Interest Burden | 1.28 | 0.92 | 0.91 | 0.87 | 0.72 |
| Research & Development to Revenue | 0.09 | 0.09 | 0.09 | 0.08 | 0.07 |
| SG&A to Revenue | 0.12 | 0.12 | 0.09 | 0.10 | 0.11 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Income Quality | 0.63 | 1.44 | 1.93 | 0.88 | -2.10 |
Currency in TWD
